Showing results (791-800 of 17,006) with videos related to

Sort By:
Pageof 1,701
Bioorganic & Medicinal Chemistry|July 15, 2010
Globostelletins A-I, cytotoxic isomalabaricane derivatives from the marine sponge Rhabdastrella globostellataJin Li, Bo Xu, Jinrong Cui, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
Dimethylaminopyridine derivatives of lupane triterpenoids are potent disruptors of mitochondrial structure and functionJon Holy, Oksana Kolomitsyna, Dmytro Krasutsky, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubineYing-Hong Li, Yi Li, Peng Yang, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
Synthesis, biological evaluation, and structure-activity relationship study of novel cytotoxic aza-caffeic acid derivativesHongbin Zou, Hao Wu, Xiangnan Zhang, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinonesPernilla Ortqvist, Johan Gising, Angelica E Ehrenberg, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonistJinhwa Lee, Hee Jeong Seo, Suk Ho Lee, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
New effective inhibitors of the Abelson kinaseGeorge A Kraus, Vinayak Gupta, Marjan Mokhtarian, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
Glycopeptide dendrimer colchicine conjugates targeting cancer cellsEmma M V Johansson, Joëlle Dubois, Tamis Darbre, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
Synthesis and properties of triplex-forming oligonucleotides containing 2'-O-(2-methoxyethyl)-5-(3-aminoprop-1-ynyl)-uridineChenguang Lou, Qiang Xiao, Lavinia Brennan, et al.
Bioorganic & Medicinal Chemistry|July 14, 2010
Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronateKristina Djanashvili, Timo L M ten Hagen, Roy Blangé, et al.
Pageof 1,701